OLEMA PHARMACEUTICALS, INC. Shareholders' Equity
OLEMA PHARMACEUTICALS, INC. (OLMA) had Shareholders' Equity of $430.56 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-10
- 2026-06-30: Stockholders' Equity Attributable to Parent $430.56M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $480.48M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $478.56M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $307.49M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $430.56M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $480.48M 10-Q · filed 2026-08-10 |
| 2025-12-31 | $478.56M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $307.49M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $345.24M 10-Q · filed 2026-08-10 |
| 2025-03-31 | $383.45M 10-Q · filed 2026-08-10 |
| 2024-12-31 | $408.96M 10-Q · filed 2026-08-10 |
| 2024-09-30 | $198.91M 10-Q · filed 2025-11-10 |
| 2024-06-30 | $227.16M 10-Q · filed 2025-11-10 |
| 2024-03-31 | $236.32M 10-Q · filed 2025-08-11 |
| 2023-12-31 | $253.90M 10-K · filed 2026-03-16 |
| 2023-09-30 | $275.13M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $161.58M 10-Q · filed 2024-11-12 |
| 2023-03-31 | $174.97M 10-Q · filed 2024-08-06 |
| 2022-12-31 | $197.55M 10-K · filed 2025-03-18 |
| 2022-09-30 | $217.70M 10-Q · filed 2023-11-07 |
| 2022-06-30 | $236.28M 10-Q · filed 2023-11-07 |
| 2022-03-31 | $265.09M 10-Q · filed 2023-08-08 |
| 2021-12-31 | $284.57M 10-K · filed 2024-03-11 |
| 2021-09-30 | $300.89M 10-Q · filed 2022-11-08 |
| 2021-06-30 | $314.08M 10-Q · filed 2022-11-08 |
| 2021-03-31 | $326.02M 10-Q · filed 2022-08-09 |
| 2020-12-31 | $338.14M 10-K · filed 2023-03-09 |
| 2020-09-30 | -$22.96M 10-Q · filed 2021-11-10 |
| 2020-06-30 | -$13.95M 10-Q · filed 2021-11-10 |
| 2020-03-31 | -$11.65M 10-Q · filed 2021-08-10 |
| 2019-12-31 | -$10.59M 10-K · filed 2022-02-28 |
| 2018-12-31 | -$8.40M 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |